215 related articles for article (PubMed ID: 34405519)
1. Dissection of 4L lymph node for left-sided non-small cell lung cancer: a meta-analysis.
Deng HY; Li D; Qiu XM; Zhu DX; Tang X; Zhou Q
ANZ J Surg; 2021 Nov; 91(11):E696-E702. PubMed ID: 34405519
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of 4L lymph node dissection in left-side operable non-small-cell lung cancer: a meta-analysis.
Peng L; Huang KL; Shang QW; Wang Y; Li W
Updates Surg; 2024 Jan; 76(1):23-32. PubMed ID: 37938527
[TBL] [Abstract][Full Text] [Related]
3. Survival Benefit of Left Lower Paratracheal (4L) Lymph Node Dissection for Patients with Left-Sided Non-small Cell Lung Cancer: Once Neglected But of Great Importance.
Zhao K; Wei S; Mei J; Guo C; Hai Y; Chen N; Liu L
Ann Surg Oncol; 2019 Jul; 26(7):2044-2052. PubMed ID: 31011902
[TBL] [Abstract][Full Text] [Related]
4. The impact of station 4L lymph node dissection on short-term and long-term outcomes in non-small cell lung cancer.
Wo Y; Li H; Zhang Y; Peng Y; Wu Z; Liu P; Shang Y; Hu H; Zhang Y; Xiang J; Sun Y
Lung Cancer; 2022 Aug; 170():141-147. PubMed ID: 35780588
[TBL] [Abstract][Full Text] [Related]
5. The impact of left lower paratracheal (4L) lymph node dissection on survival in patients with surgically treated left-sided NSCLC.
Gryszko GM; Cackowski MM; Zbytniewski M; Woźnica K; Orłowski TM; Dziedzic DA;
Eur J Cardiothorac Surg; 2021 Nov; 60(5):1201-1209. PubMed ID: 34279610
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of 4L Lymph Node Dissection in Left Lung Cancer.
Wang YN; Yao S; Wang CL; Li MS; Sun LN; Yan QN; Tang SW; Zhang ZF
J Clin Oncol; 2018 Oct; 36(29):2935-2942. PubMed ID: 30148659
[TBL] [Abstract][Full Text] [Related]
7. Predictors and survival impact of station 4L metastasis in left non-small cell lung cancer.
Fang L; Wang L; Wang Y; Wu Y; Ye P; Lv W; Hu J
J Cancer Res Clin Oncol; 2019 May; 145(5):1313-1319. PubMed ID: 30877377
[TBL] [Abstract][Full Text] [Related]
8. Clinical Significance of Station 3A Lymph Node Dissection in Patients with Right-Side Non-Small-Cell Lung Cancer: A Retrospective Propensity-Matched Analysis.
Liu C; Wei S; Guo C; Mei J; Pu Q; Liu L
Ann Surg Oncol; 2021 Jan; 28(1):194-202. PubMed ID: 32638165
[TBL] [Abstract][Full Text] [Related]
9. Impact of L4 lymph node dissection on long-term survival in left-side operable non-small-cell lung cancer: a propensity score matching study.
Yang MZ; Hou X; Li JB; Cai JS; Yang J; Li S; Long H; Fu JH; Zhang LJ; Lin P; Rong TH; Yang HX
Eur J Cardiothorac Surg; 2020 Jun; 57(6):1181-1188. PubMed ID: 32016340
[TBL] [Abstract][Full Text] [Related]
10. Station 3A lymph node dissection does not improve long-term survival in right-side operable non-small-cell lung cancer patients: A propensity score matching study.
Yang MZ; Tan ZH; Li JB; Long H; Fu JH; Zhang LJ; Lin P; Hou X; Yang HX
Thorac Cancer; 2022 Aug; 13(15):2106-2116. PubMed ID: 35702992
[TBL] [Abstract][Full Text] [Related]
11. Complete dissection of right paratracheal lymph nodes (stations 2R and 4R) is critical to improve the prognosis of lung cancer patients: A retrospective cohort study.
Zhao K; Mei J; Hu B; Guo C; Wei S; Yang X; Yang Z; Zhang J; Ku Y; Zheng Y; Wu D; Li S; Mao Y; Ding Y; Liu L
Thorac Cancer; 2023 Nov; 14(33):3309-3316. PubMed ID: 37789589
[TBL] [Abstract][Full Text] [Related]
12. Significance of risk factor analysis and dissection for station 4L lymphatic metastasis in left lung cancer: a systematic review and meta-analysis.
Wang CX; Xu C; Li C; Ding C; Chen J; Zhao J
Transl Cancer Res; 2021 Apr; 10(4):1656-1666. PubMed ID: 35116491
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and survival outcomes of 4L lymph node dissection in left lung adenocarcinoma and squamous cell carcinoma.
Shen L; Guo J; Zhang W; Liang C; Chen H; Liu Y
Front Oncol; 2023; 13():1124014. PubMed ID: 37114135
[TBL] [Abstract][Full Text] [Related]
14. Radical systematic mediastinal lymphadenectomy versus mediastinal lymph node sampling in patients with clinical stage IA and pathological stage T1 non-small cell lung cancer.
Ma K; Chang D; He B; Gong M; Tian F; Hu X; Ji Z; Wang T
J Cancer Res Clin Oncol; 2008 Dec; 134(12):1289-95. PubMed ID: 18504610
[TBL] [Abstract][Full Text] [Related]
15. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer.
Gajra A; Newman N; Gamble GP; Kohman LJ; Graziano SL
J Clin Oncol; 2003 Mar; 21(6):1029-34. PubMed ID: 12637467
[TBL] [Abstract][Full Text] [Related]
16. Lobe-Specific Node Dissection Can Be a Suitable Alternative to Systematic Lymph Node Dissection in Highly Selective Early-Stage Non-Small-Cell Lung Cancer Patients: A Meta-Analysis.
Wang Z; Qi Z; Cheng D; Hao X; Pu Q; Liu L
Ann Thorac Cardiovasc Surg; 2021 Jun; 27(3):143-150. PubMed ID: 33281131
[TBL] [Abstract][Full Text] [Related]
17. Should the left lower paratracheal lymph node always be dissected in patients with left-sided lung cancer?
Deng HY; Wang T; Tang X
Eur J Cardiothorac Surg; 2020 Aug; 58(2):404. PubMed ID: 32215627
[No Abstract] [Full Text] [Related]
18. Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: a multicentre analysis†.
Chiappetta M; Leuzzi G; Sperduti I; Bria E; Mucilli F; Lococo F; Spaggiari L; Ratto GB; Filosso PL; Facciolo F
Eur J Cardiothorac Surg; 2019 Mar; 55(3):405-412. PubMed ID: 30202953
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological characteristics and risk factors of station 4L lymph node metastasis of left non-small cell lung cancer].
Shen L; Yun T; Guo J; Liu Y; Liang C
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Dec; 40(12):1793-1798. PubMed ID: 33380404
[TBL] [Abstract][Full Text] [Related]
20. [Survival Analysis of Stage I Non-small Cell Lung Cancer Patients Treated with
Da Vinci Robot-assisted Thoracic Surgery].
Liu X; Xu S; Liu B; Xu W; Ding R; Wang T; Li B; Wang X; Wu Q; Teng H; Wang S
Zhongguo Fei Ai Za Zhi; 2018 Nov; 21(11):849-856. PubMed ID: 30454547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
